Skip to main content
Erschienen in: Pathology & Oncology Research 2/2017

28.12.2016 | Short Communication

The General Expression Analysis of WTX Gene in Normal and Cancer Tissues

verfasst von: Yao-Yao Zhang, Qi-Ming Wang, Hui-Lin Niu, Xia Liu, Qing-Ling Zhang

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

WTX (Wilms’ tumor suppressor X chromosome) is a novel putative tumor suppressor gene in Wilms’ tumor of kidney, its expression and function in other human cancers had not been explored. This study detected the expression of WTX in 459 cases of 15 organs of cancers and adjacent normal tissues by using immunohistochemical staining (IHC), and validated them by in situ hybridization (ISH) and quantitative real-time reverse transcription PCR (qRT-PCR). IHC and ISH data showed that WTX protein was generally expressed in normal tissues, but reduced expression in corresponding cancers. This study demonstrated that WTX downregulation is a common phenomenon in human cancers, WTX might be a general tumor-suppressor gene and biological marker of multiple cancer tissues. Apart from kidney, stomach is another target tissue of WTX gene. The germline and somatic mutations of WTX were screened in 12 gastric cancer patients and identified in one cases (8.3%). Mutation in the WTX gene might be one of the reasons of WTX loss in gastric cancer patients.
Literatur
1.
Zurück zum Zitat Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315(5812):642–645CrossRefPubMed Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315(5812):642–645CrossRefPubMed
2.
Zurück zum Zitat Alexandrescu, S., S. Akhavanfard, M.H. Harris, and S.O. Vargas, Clinical, pathologic, and genetic features of Wilms tumors with WTX gene mutation. Pediatr Dev Pathol, 2016. Alexandrescu, S., S. Akhavanfard, M.H. Harris, and S.O. Vargas, Clinical, pathologic, and genetic features of Wilms tumors with WTX gene mutation. Pediatr Dev Pathol, 2016.
3.
Zurück zum Zitat X-ing Out Tumor Suppression. Science, 2007. 315: p. 569 h. X-ing Out Tumor Suppression. Science, 2007. 315: p. 569 h.
4.
5.
Zurück zum Zitat Kim MK, Min DJ, Rabin M, Licht JD (2011) Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants. Oncogene 30(7):832–842CrossRefPubMed Kim MK, Min DJ, Rabin M, Licht JD (2011) Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants. Oncogene 30(7):832–842CrossRefPubMed
6.
Zurück zum Zitat Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Minaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Ades LC, Tchan M, David A, Wilson LC, Hennekam RC, Donnai D, Mansour S, Cormier-Daire V, Robertson SP (2009) Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet 41(1):95–100CrossRefPubMed Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Minaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Ades LC, Tchan M, David A, Wilson LC, Hennekam RC, Donnai D, Mansour S, Cormier-Daire V, Robertson SP (2009) Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet 41(1):95–100CrossRefPubMed
7.
Zurück zum Zitat Fujita A, Ochi N, Fujimaki H, Muramatsu H, Takahashi Y, Natsume J, Kojima S, Nakashima M, Tsurusaki Y, Saitsu H, Matsumoto N, Miyake N (2014) A novel WTX mutation in a female patient with osteopathia striata with cranial sclerosis and hepatoblastoma. Am J Med Genet A 164A(4):998–1002CrossRefPubMed Fujita A, Ochi N, Fujimaki H, Muramatsu H, Takahashi Y, Natsume J, Kojima S, Nakashima M, Tsurusaki Y, Saitsu H, Matsumoto N, Miyake N (2014) A novel WTX mutation in a female patient with osteopathia striata with cranial sclerosis and hepatoblastoma. Am J Med Genet A 164A(4):998–1002CrossRefPubMed
8.
Zurück zum Zitat Comai G, Boutet A, Neirijnck Y, Schedl A (2010) Expression patterns of the Wtx/Amer gene family during mouse embryonic development. Dev Dyn 239(6):1867–1878CrossRefPubMed Comai G, Boutet A, Neirijnck Y, Schedl A (2010) Expression patterns of the Wtx/Amer gene family during mouse embryonic development. Dev Dyn 239(6):1867–1878CrossRefPubMed
9.
Zurück zum Zitat He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S (2006) Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 210(3):288–297CrossRefPubMed He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S (2006) Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 210(3):288–297CrossRefPubMed
10.
Zurück zum Zitat Qingling Z, Lina Y, Li L, Shuang W, Yufang Y, Yi D, Divakaran J, Xin L, Yanqing D (2011) LMP1 antagonizes WNT/beta-catenin signalling through inhibition of WTX and promotes nasopharyngeal dysplasia but not tumourigenesis in LMP1(B95-8) transgenic mice. J Pathol 223(5):574–583CrossRefPubMed Qingling Z, Lina Y, Li L, Shuang W, Yufang Y, Yi D, Divakaran J, Xin L, Yanqing D (2011) LMP1 antagonizes WNT/beta-catenin signalling through inhibition of WTX and promotes nasopharyngeal dysplasia but not tumourigenesis in LMP1(B95-8) transgenic mice. J Pathol 223(5):574–583CrossRefPubMed
11.
Zurück zum Zitat Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss MJ, Angers S, Moon RT (2007) Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316(5827):1043–1046CrossRefPubMed Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss MJ, Angers S, Moon RT (2007) Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316(5827):1043–1046CrossRefPubMed
12.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408CrossRefPubMed
13.
Zurück zum Zitat Armat M, Ramezani F, Molavi O, Sabzichi M, Samadi N (2016) Six family of homeobox genes and related mechanisms in tumorigenesis protocols. Tumori:0 Armat M, Ramezani F, Molavi O, Sabzichi M, Samadi N (2016) Six family of homeobox genes and related mechanisms in tumorigenesis protocols. Tumori:0
14.
Zurück zum Zitat Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY, Samarut J, Plateroti M (2010) Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 138(5):1863–1874CrossRefPubMed Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY, Samarut J, Plateroti M (2010) Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 138(5):1863–1874CrossRefPubMed
15.
Zurück zum Zitat Rivlin N, Brosh R, Oren M, Rotter V (2011) Mutations in the p53 tumor suppressor Gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2(4):466–474CrossRefPubMedPubMedCentral Rivlin N, Brosh R, Oren M, Rotter V (2011) Mutations in the p53 tumor suppressor Gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2(4):466–474CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Holloway KR, Sinha VC, Bu W, Toneff M, Dong J, Peng Y, Li Y (2016) Targeting oncogenes into a defined subset of mammary cells demonstrates that the initiating oncogenic mutation defines the resulting tumor phenotype. Int J Biol Sci 12(4):381–388CrossRefPubMedPubMedCentral Holloway KR, Sinha VC, Bu W, Toneff M, Dong J, Peng Y, Li Y (2016) Targeting oncogenes into a defined subset of mammary cells demonstrates that the initiating oncogenic mutation defines the resulting tumor phenotype. Int J Biol Sci 12(4):381–388CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Zhou QM, Li W, Zhang X, Chen YB, Chen XC, Guan YX, Ding Y, Wen XZ, Xia Q, Zhou Q, Peng RQ, Hou JH, Zhu XF, Zeng YX, Zhang XS (2012) The mutation profiles of common oncogenes involved in melanoma in southern China. J Invest Dermatol 132(7):1935–1937CrossRefPubMed Zhou QM, Li W, Zhang X, Chen YB, Chen XC, Guan YX, Ding Y, Wen XZ, Xia Q, Zhou Q, Peng RQ, Hou JH, Zhu XF, Zeng YX, Zhang XS (2012) The mutation profiles of common oncogenes involved in melanoma in southern China. J Invest Dermatol 132(7):1935–1937CrossRefPubMed
18.
Zurück zum Zitat Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E (2015) A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors. BMC Cancer 15:157CrossRefPubMedPubMedCentral Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E (2015) A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors. BMC Cancer 15:157CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Perotti D, Gamba B, Sardella M, Spreafico F, Terenziani M, Collini P, Pession A, Nantron M, Fossati-Bellani F, Radice P (2008) Functional inactivation of the WTX gene is not a frequent event in Wilms’ tumors. Oncogene 27(33):4625–4632CrossRefPubMed Perotti D, Gamba B, Sardella M, Spreafico F, Terenziani M, Collini P, Pession A, Nantron M, Fossati-Bellani F, Radice P (2008) Functional inactivation of the WTX gene is not a frequent event in Wilms’ tumors. Oncogene 27(33):4625–4632CrossRefPubMed
20.
Zurück zum Zitat Fukuzawa R, Holman SK, Chow CW, Savarirayan R, Reeve AE, Robertson SP (2010) WTX mutations can occur both early and late in the pathogenesis of Wilms tumour. J Med Genet 47(11):791–794CrossRefPubMed Fukuzawa R, Holman SK, Chow CW, Savarirayan R, Reeve AE, Robertson SP (2010) WTX mutations can occur both early and late in the pathogenesis of Wilms tumour. J Med Genet 47(11):791–794CrossRefPubMed
21.
Zurück zum Zitat Scheel SK, Porzner M, Pfeiffer S, Ormanns S, Kirchner T, Jung A (2010) Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. BMC Cancer 10:413CrossRefPubMedPubMedCentral Scheel SK, Porzner M, Pfeiffer S, Ormanns S, Kirchner T, Jung A (2010) Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. BMC Cancer 10:413CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Chung NG, Kim MS, Chung YJ, Yoo NJ, Lee SH (2008) Tumor suppressor WTX gene mutation is rare in acute leukemias. Leuk Lymphoma 49(8):1616–1617CrossRefPubMed Chung NG, Kim MS, Chung YJ, Yoo NJ, Lee SH (2008) Tumor suppressor WTX gene mutation is rare in acute leukemias. Leuk Lymphoma 49(8):1616–1617CrossRefPubMed
23.
Zurück zum Zitat Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S (2008) Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 456(7218):125–129CrossRefPubMedPubMedCentral Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S (2008) Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 456(7218):125–129CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Liu X, Wang Q, Niu H, Yang X, Sun J, Zhang Q, Ding Y (2013) Promoter methylation of Wilms’ tumor gene on the X- chromosome in gastric cancer. Nan Fang Yi Ke Da Xue Xue Bao 33(3):318–321PubMed Liu X, Wang Q, Niu H, Yang X, Sun J, Zhang Q, Ding Y (2013) Promoter methylation of Wilms’ tumor gene on the X- chromosome in gastric cancer. Nan Fang Yi Ke Da Xue Xue Bao 33(3):318–321PubMed
Metadaten
Titel
The General Expression Analysis of WTX Gene in Normal and Cancer Tissues
verfasst von
Yao-Yao Zhang
Qi-Ming Wang
Hui-Lin Niu
Xia Liu
Qing-Ling Zhang
Publikationsdatum
28.12.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2017
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0168-0

Weitere Artikel der Ausgabe 2/2017

Pathology & Oncology Research 2/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.